share_log

Marker Therapeutics Shares Are Trading Higher After the Company Announced It Won a $9.5 Million Grant to Study Pancreatic Cancer Therapy.

Marker Therapeutics Shares Are Trading Higher After the Company Announced It Won a $9.5 Million Grant to Study Pancreatic Cancer Therapy.

Marker Therapeutics的股票在公司宣布赢得了950万美元的赠款用于研究胰腺癌疗法后,交易价格上涨。
Benzinga ·  12/17 08:35

Marker Therapeutics Shares Are Trading Higher After the Company Announced It Won a $9.5 Million Grant to Study Pancreatic Cancer Therapy.

Marker Therapeutics的股票在公司宣布赢得了950万美元的赠款用于研究胰腺癌疗法后,交易价格上涨。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发